65 related articles for article (PubMed ID: 9346854)
1. Idiotype specific peptides bind to the surface immunoglobulins of two murine B-cell lymphoma lines, inducing signal transduction.
Lam KS; Lou Q; Zhao ZG; Smith J; Chen ML; Pleshko E; Salmon SE
Biomed Pept Proteins Nucleic Acids; 1995; 1(3):205-10. PubMed ID: 9346854
[TBL] [Abstract][Full Text] [Related]
2. B-lymphoma cells are activated by peptide ligands of the antigen binding receptor or by anti-idiotypic antibody to induce extracellular acidification.
Renschler MF; Wada HG; Fok KS; Levy R
Cancer Res; 1995 Dec; 55(23):5642-7. PubMed ID: 7585648
[TBL] [Abstract][Full Text] [Related]
3. Identification of specific peptide ligands for B-lymphoma cell and its effect on tyrosine phosphorylation and cell apoptosis.
Song L; Ma X; Cui X; Li Y; Wang X
Chin Med Sci J; 2004 Mar; 19(1):44-50. PubMed ID: 15104224
[TBL] [Abstract][Full Text] [Related]
4. Treatment of B-cell lymphoma using peptides. A novel concept.
Lam KS
West J Med; 1993 May; 158(5):475-9. PubMed ID: 8342262
[TBL] [Abstract][Full Text] [Related]
5. From combinatorial chemistry to cancer-targeting peptides.
Aina OH; Liu R; Sutcliffe JL; Marik J; Pan CX; Lam KS
Mol Pharm; 2007; 4(5):631-51. PubMed ID: 17880166
[TBL] [Abstract][Full Text] [Related]
6. Somatically mutated regions of immunoglobulin on human B-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cells.
Gricks CS; Rawlings E; Foroni L; Madrigal JA; Amlot PL
Cancer Res; 2001 Jul; 61(13):5145-52. PubMed ID: 11431353
[TBL] [Abstract][Full Text] [Related]
7. Selection of chronic lymphocytic leukemia binding peptides.
Takahashi S; Mok H; Parrott MB; Marini FC; Andreeff M; Brenner MK; Barry MA
Cancer Res; 2003 Sep; 63(17):5213-7. PubMed ID: 14500347
[TBL] [Abstract][Full Text] [Related]
8. Generation and selection of immunized Fab phage display library against human B cell lymphoma.
Shen Y; Yang X; Dong N; Xie X; Bai X; Shi Y
Cell Res; 2007 Jul; 17(7):650-60. PubMed ID: 17621306
[TBL] [Abstract][Full Text] [Related]
9. Peptide ligands that bind IgM antibodies and block interaction with antigen.
Glee PM; Pincus SH; McNamer DK; Smith MJ; Burritt JB; Cutler JE
J Immunol; 1999 Jul; 163(2):826-33. PubMed ID: 10395676
[TBL] [Abstract][Full Text] [Related]
10. Identification of a neuritogenic ligand of the neural cell adhesion molecule using a combinatorial library of synthetic peptides.
Rønn LC; Olsen M; Ostergaard S; Kiselyov V; Berezin V; Mortensen MT; Lerche MH; Jensen PH; Soroka V; Saffell JL; Doherty P; Poulsen FM; Bock E; Holm A
Nat Biotechnol; 1999 Oct; 17(10):1000-5. PubMed ID: 10504702
[TBL] [Abstract][Full Text] [Related]
11. Discovery of high-affinity peptide ligands for vancomycin.
Yao N; Wu CY; Xiao W; Lam KS
Biopolymers; 2008; 90(3):421-32. PubMed ID: 18260149
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel peptide ligand of human vascular endothelia growth factor receptor 3 for targeted tumour diagnosis and therapy.
Qin X; Wan Y; Li M; Xue X; Wu S; Zhang C; You Y; Wang W; Jiang C; Liu Y; Zhu W; Ran Y; Zhang Z; Han W; Zhang Y
J Biochem; 2007 Jul; 142(1):79-85. PubMed ID: 17517791
[TBL] [Abstract][Full Text] [Related]
13. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
Demirgöz D; Garg A; Kokkoli E
Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
[TBL] [Abstract][Full Text] [Related]
14. Screening and identification of a peptide specifically targeted to NCI-H1299 from a phage display peptide library.
Zang L; Shi L; Guo J; Pan Q; Wu W; Pan X; Wang J
Cancer Lett; 2009 Aug; 281(1):64-70. PubMed ID: 19327883
[TBL] [Abstract][Full Text] [Related]
15. A tyrosine-based signal present in Ig alpha mediates B cell receptor constitutive internalization.
Cassard S; Salamero J; Hanau D; Spehner D; Davoust J; Fridman WH; Bonnerot C
J Immunol; 1998 Feb; 160(4):1767-73. PubMed ID: 9469435
[TBL] [Abstract][Full Text] [Related]
16. Identification of CD19 and CD20 peptides for induction of antigen-specific CTLs against B-cell malignancies.
Bae J; Martinson JA; Klingemann HG
Clin Cancer Res; 2005 Feb; 11(4):1629-38. PubMed ID: 15746068
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel peptide ligands for the cancer-specific receptor mutation EFGRvIII using a mixture-based synthetic combinatorial library.
Denholt CL; Hansen PR; Pedersen N; Poulsen HS; Gillings N; Kjaer A
Biopolymers; 2009 Mar; 91(3):201-6. PubMed ID: 19107925
[TBL] [Abstract][Full Text] [Related]
18. Asymmetrical phosphorylation and function of immunoreceptor tyrosine-based activation motif tyrosines in B cell antigen receptor signal transduction.
Pao LI; Famiglietti SJ; Cambier JC
J Immunol; 1998 Apr; 160(7):3305-14. PubMed ID: 9531288
[TBL] [Abstract][Full Text] [Related]
19. Interaction of HLA-E with peptides and the peptide transporter in vitro: implications for its function in antigen presentation.
Ulbrecht M; Modrow S; Srivastava R; Peterson PA; Weiss EH
J Immunol; 1998 May; 160(9):4375-85. PubMed ID: 9574542
[TBL] [Abstract][Full Text] [Related]
20. IgM expressed by leukemic CD5(+) B cells binds mouse immunoglobulin light chain.
Weston KM; Tangye SG; Dunn RD; Smith A; Morris MB; Raison RL
J Mol Recognit; 2001; 14(4):245-53. PubMed ID: 11500971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
